Kurtoglu Metin
Insider CIK 2000284 · RNAC Chief Technology Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAC Cartesian Therapeutics, In | S Sale | 2025-01-06 | 2025-01-07 | 2,458 | $16.83 | $41.4K | 62,258 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2025-01-03 | 2025-01-07 | 2,417 | $16.72 | $40.4K | 64,716 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2025-01-02 | 2025-01-06 | 47,400 | — | $0 | 47,400 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2025-01-02 | 2025-01-06 | 16,100 | — | $0 | 67,133 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-12-10 | 2024-12-11 | 2,901 | — | $0 | 79,099 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-12-10 | 2024-12-11 | 2,901 | $24.35 | $70.6K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-12-10 | 2024-12-11 | 2,901 | $1.41 | $4.1K | 53,934 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-12-09 | 2024-12-11 | 10,763 | — | $0 | 82,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-12-09 | 2024-12-11 | 6,224 | $25.26 | $157.2K | 55,572 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-12-09 | 2024-12-11 | 4,539 | $25.83 | $117.2K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-12-09 | 2024-12-11 | 10,763 | $1.41 | $15.2K | 61,796 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-21 | 2024-11-21 | 32,789 | — | $0 | 92,763 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-21 | 2024-11-21 | 32,789 | $1.41 | $46.2K | 83,822 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-21 | 2024-11-21 | 32,789 | $16.67 | $546.6K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-20 | 2024-11-21 | 5,700 | — | $0 | 125,552 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-20 | 2024-11-21 | 5,700 | $1.41 | $8.0K | 56,733 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-20 | 2024-11-21 | 5,600 | $17.28 | $96.8K | 51,133 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-20 | 2024-11-21 | 100 | $18.09 | $1.8K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-19 | 2024-11-21 | 200 | — | $0 | 131,252 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-19 | 2024-11-21 | 200 | $1.41 | $282 | 51,233 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-19 | 2024-11-21 | 200 | $19.50 | $3.9K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-18 | 2024-11-18 | 34,400 | — | $0 | 131,452 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-18 | 2024-11-18 | 17,728 | $18.58 | $329.4K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-18 | 2024-11-18 | 16,672 | $18.19 | $303.3K | 68,761 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-18 | 2024-11-18 | 34,400 | $1.41 | $48.5K | 85,433 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-15 | 2024-11-18 | 22,068 | — | $0 | 165,852 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-15 | 2024-11-18 | 22,068 | $17.20 | $379.6K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-15 | 2024-11-18 | 22,068 | $1.41 | $31.1K | 73,101 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-11-14 | 2024-11-18 | 25,900 | — | $0 | 187,920 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise | 2024-11-14 | 2024-11-18 | 25,900 | $1.41 | $36.5K | 76,933 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-14 | 2024-11-18 | 4,000 | $17.06 | $68.2K | 51,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | S Sale | 2024-11-14 | 2024-11-18 | 21,900 | $16.33 | $357.6K | 55,033 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 213,820 | — | $0 | 213,820 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 14,254 | — | $0 | 14,254 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 428 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 14,254 | — | $0 | 14,254 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 428 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | M Exercise deriv | 2024-04-08 | 2024-04-10 | 6,415 | — | $0 | 0 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2024-01-02 | 2024-01-04 | 1,965,000 | — | $0 | 1,965,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award | 2024-01-02 | 2024-01-04 | 1,531,000 | — | $0 | 1,531,000 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2023-11-13 | 2023-11-15 | 428 | — | $0 | 428 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2023-11-13 | 2023-11-15 | 428 | — | $0 | 428 | SEC↗ |
| RNAC Cartesian Therapeutics, In | A Award deriv | 2023-11-13 | 2023-11-15 | 6,415 | — | $0 | 6,415 | SEC↗ |